BioLife Solutions Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	-3.21	-20.18	-68	-139.81	-8.91	1.98
Depreciation & Amortization	5.81	8.66	12.3	16.47	12.87	5.07
Stock-Based Compensation	26.61	30.92	33.25	25.33	13.96	5.98
Other Adjustments	8.7	-11.2	8.5	104.42	-20.25	-5.29
Change in Receivables	-2.91	-2.9	15.35	-10.75	-10.13	-1.79
Changes in Inventories	-0.28	0.78	-8.55	-6.56	0.11	-0.63
Changes in Accounts Payable	0.03	0.03	-8.43	0.41	2.02	-0.17
Changes in Accrued Expenses	4.76	6.49	2	1.79	-3.94	0.78
Changes in Other Operating Activities	-3.17	-4.17	1.09	0.21	9.68	0.71
Operating Cash Flow	42.6	8.43	-12.5	-8.49	-4.59	6.65
Operating Cash Flow Growth	1073.43%	-	-	-	-	447.82%
Capital Expenditures	-5.98	-3.23	-6.38	-10.39	-8.39	-4.63
Sale of Property, Plant & Equipment	-	-	-	-	0.01	0.04
Purchases of Intangible Assets	-5.11	-0.3	-	-	-	-
Purchases of Investments	-79.79	-18.42	-27.1	-53.12	-	-2
Proceeds from Sale of Investments	26.65	21.92	56.17	8.92	-	-
Payments for Business Acquisitions	-	-	-	-	-	-14.95
Proceeds from Business Divestments	-	73.43	-	-	-	-
Other Investing Activities	-0.83	-15.11	-4.86	-3.54	-4.81	-3.18
Investing Cash Flow	0.96	58.3	17.84	-58.12	-13.19	-24.72
Short-Term Debt Issued	-	-	-	-	27.31	2.18
Short-Term Debt Repaid	-	-	-	-	-31.54	-2.18
Net Short-Term Debt Issued (Repaid)	-	-	-	-	-4.23	-
Long-Term Debt Issued	-	-	-	20	1.55	0.98
Long-Term Debt Repaid	-10.93	-6.61	-0.5	-2.16	-0.21	-
Net Long-Term Debt Issued (Repaid)	-10.93	-6.61	-0.5	17.84	1.34	0.98
Issuance of Common Stock	0.08	0.2	10.75	0.32	1.42	101.63
Net Common Stock Issued (Repurchased)	0.08	0.2	10.75	0.32	1.42	101.63
Other Financing Activities	-1.67	-0.38	0.34	-1.84	-1.3	-0.54
Financing Cash Flow	-12.51	-6.78	10.59	16.32	-2.78	102.08
Net Cash Flow	31.04	59.95	15.93	-50.29	-20.56	84.01
Free Cash Flow	6.4	5.2	-18.88	-18.87	-12.98	2.01
Free Cash Flow Growth	22.91%	-	-	-	-	-
FCF Margin	6.75%	6.33%	-24.89%	-24.76%	-10.89%	4.18%
Free Cash Flow Per Share	0.13	0.11	-0.43	-0.44	-0.34	0.07
Levered Free Cash Flow	-25.61	-18.23	-76.47	-120.03	-38.71	-2.44
Unlevered Free Cash Flow	13.91	1.4	-31.45	-11.23	-48.02	-21.02

Updated Nov 6, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q